Biotech Investment Analyst — Drug Asset & Company Assessment

Position Type: Part-Time Contract
Location: Remote — United States
Compensation: $120–$200/hour
Engagement: Approximately 10–20 hours over a 1–2 week pilot

About the Role

We are seeking an experienced Biotech Investment Analyst with a specialist-fund background to support expert evaluation work focused on commercial drugs and drug-development programs.

You will assess biotech companies and drug assets from an investment perspective, evaluating clinical data, mechanisms, competitive positioning, value drivers, and the overall strength of investment theses.

The engagement begins with a short paid pilot, with potential for recurring work as the project expands.

Key Responsibilities

• Create and critique rubrics for evaluating commercial drugs and drug-development programs.

• Assess companies and drug assets across:

  • Mechanism of action

  • Clinical data

  • Competitive position

  • Key value drivers

• Evaluate the strength and quality of investment-style theses.

• Identify weak, overconfident, unsupported, or missing assumptions.

• Conduct end-to-end assessments of assigned biotech companies and their drug assets.

• Apply your investment expertise across approximately 5–10 companies during the pilot.

Requirements

• US-based biotech or healthcare investment analyst with specialist-fund experience.

• 5+ years of experience evaluating biotech or pharmaceutical companies and/or drug assets.

• Strong familiarity with biotech and pharmaceutical development programs.

• Demonstrated ability to assess drug assets and the companies behind them from an investment perspective.

• Strong understanding of clinical development, competitive positioning, and biotech value drivers.

• Ability to critically evaluate investment assumptions and theses.

Engagement Details

• Format: Fully remote

• Initial engagement: Approximately 10–20 hours

• Pilot duration: 1–2 weeks

• Schedule: Flexible, subject to project requirements

• Contract: Independent contractor

• Potential: Recurring opportunities for strong contributors

Why Participate?

• Apply your biotech investment expertise to emerging AI evaluation work.

• Help improve expert-level assessment of pharmaceutical drugs and development programs.

• Contribute investment-focused perspectives to the evaluation of biotech companies and assets.

• Potential for continued engagement as the work scales.

Contract & Payment Terms

• Projects may be extended, shortened, or concluded early based on project needs and performance.

• Work will not involve access to confidential or proprietary information from any employer, client, or institution.

• Payments are made weekly through Stripe or Wise based on services rendered.

• H1-B and STEM OPT candidates cannot be supported at this time.

We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.